The global biosimilars market is expected to reach USD 13.1 billion by 2024 on account of increase in the prevalence of chronic diseases such as cancer, diabetics, cardiac disorders and autoimmune diseases. Rising demand for the cost-effective therapies is expected to drive the market in the forecast period. Biosimilars are about 30% cheaper ... Read more

Biosimilars are biological medical products that are developed to be similar to an already licensed biological product, known as reference medicinal product (RPM). Biosimilars offer an effective alternate to expensive biopharmaceutical drugs with similar quality, safety, and efficacy. They seek to expand patient access to lifesaving medicines by reducing costs. For example, biosimilars have the potential to treat various chronic diseases like cancer, diabetes, and autoimmune conditions at a ... Read more